A 50-year-old Japanese manwith Grave's disease had been taking propylthiouracil (PTU) for 10 years prior to the diagnosis of pneumonia. He noticed dyspnea on exertion and had a dry cough for at least 2 years and then 
Introduction
Although propylthiouracil (PTU) is an effective treatment for Graves' disease, on rare occasion a variety of adverse reactions arise including agranulocytosis, hepatitis, unexplained fever, exfoliative dermatitis, antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, nephritis, SLE-like syndrome or interstitial pneumonia (1-8). Wereport here a male patient with Graves' disease whohad been taking PTUfor 10 years who became complicated with inter- and honeycombing in the periphery and lower lungs on both sides (Fig. 1A) . The cardiothoracic ratio was 54%, indicating mild cardiomegaly. ECG showed atrial fibrillation. The PaO2 and PaCO2 were 51.2 and 38.1 mmHg, respectively. Chest computed tomography showed diffuse alveolar infiltrates ( Fig. 2A) . The serum level of KL-6, a marker of interstitial pneumonia, had increased to 2,980 U/ml. He demonstrated hyperthyroidism, with plasma levels of thyroid stimulating hormone (TSH) was suppressed to below 0.1>U/ml, while serum free triiodothyronine (T3) and free thyroxine (T4) levels were 13.3 pg/ml and 5.38 | ng/dl, respectively. TSHreceptor antibody (TRAb) was 3.7%, thyroid stimulating antibody (TSAb) was 252%, thyroid peroxidase antibody (TPO-Ab) was 6.8 U/ml and thyrogroblin antibody (Tg-Ab) was 1.0 U/ml. Several serological markers such as rheumatoid factor, anti DNA antibody or PR3-ANCAwere within normal limits, while anti-nuclear antibody was positive (x640) and MPO-ANCA was detected at 79 EU/ml. Lymphocyte stimulation assay for PTUwas negative. Cultures for bacteria, mycoplasma, and tricosporone were negative. Serumangiotensin-converting enzymewas negative. Westrongly suspected that he had PTU-induced interstitial pneumonia and stopped PTUtreatment and began 60 mg/day of prednisolone (PSL). After 14 days, symptoms such as exertional dyspnea had gradually improved. After 5 weeks of PSL, the abnormal shadowobserved on the chest roentgenogram had decreased ( Fig. IB and 2B ). After 2 months, PaO2 became 78 mmHgand he did not require oxygen therapy (Table 3) history of exposure to specific dusts or known exposure to dust. He kept a pet parakeet, but assay for serum antibody to Chlamydia psittaci was negative. Although his ANA test was positive, he showed no symptoms of collagen disease. Since we could not examine broncho-alveolar lavage (BAL) or lung biopsy, the differential diagnosis of interstitial pneumonia (IP) was not fully made. However, acute IP (AIP) usually occurs suddenly and consolidations are observed in the entire lung field on roentgenogram and steroid pulse therapy is not effective. In bronchiolitis obliterans organizing pneumonia (BOOP), which subacutely occurs, abnormal shadows of chest roentgenogram move and honeycombs shadows are rarely seen. While in this patient, the roentgenogram showed ground-glass opacities and honey combs in the periphery and lower lungs, which did not move, and steroid therapy was ef- Similarly, in the present patient, MMI was changed to PTU because of the occurrence of drug eruption due to MMI. In mild cases of interstitial pneumonia, all symptoms resolve upon cessation of PTU, while in severe cases, steroid pulse therapy or immunosuppressive drugs are nesessary (7, ll). The present patient required 60 mg/day of PSL for 2 months to completely recover from respiratory failure. The longer recovery period of our patient compared to the two abovementioned cases was due to the fact that PTU therapy c ontinued in spite of his complaint of exertional dyspnea.
The present patient showed MPO-ANCA positivity, and the level remained moderately high 2 years after withdrawal of PTU. Administration of thionamides has been reported to induce ANCA positivity.
Although Ohwadaet al was still moderately high after withdrawal of PTU, his MPOANCApositivity was thought to be the result of immunological abnormalities arising as a complication of Grave's disease, not PTU. Because Grave's disease is an autoimmune disease, autoimmune antibodies are frequently detected in these patients (8, 10, ll) .
In summary, although the incidence of interstitial pneumonia as an adverse effect of PTUis rare, interstitial pneumonia should be considered in Japanese Grave's disease patients with an allergic reaction to MMIunder PTU therapy.
